Table 2.
Trend in the GMT (95% CI) of anti-COVID-19 IgG in screened HCWs, per group.
| Variable | T0 | T1 | T2 | T3 | T4 |
|---|---|---|---|---|---|
| Sex | |||||
| Female | 14,524.8 (12,335.1–17,103.3) |
8646.0 (7933.2–9422.9) |
4733.6 (4520.9–4956.4) |
3082.2 (2889.1–3288.3) |
2252.8 (1973.0–2572.3) |
| Male | 13,551.4 (11,346.6–16,185.4) |
7393.9 (6692.3–8169.1) |
3970.4 (3699.8–4260.8) |
2584.1 (2347.4–2844.7) |
1906.1 (1560.0–2328.9) |
| Age class | |||||
| 18–35 years | 17,802.7 (13,647.2–23,117.7) |
10,302.4 (9307.7–11,403.5) |
5854.2 (5527.8–6199.9) |
3653.8 (3376.1–3954.5) |
2722.0 (2417.0–3065.4) |
| 36–50 years | 14,459.8 (12,375.0–16,985.9) |
8238.3 (7314.7–9278.5) |
4278.1 (4023.8–4.548.5) |
2748.8 (2504.8–3016.6) |
1795.9 (1486.5–2169.7) |
| 51–70 years | 11,508.3 (9368.8–14,136.4) |
6603.0 (5923.9–7359.9) |
3703.3 (3445.7–3980.2) |
2436.0 (2205.8–2690.2) |
1836.9 (1434.7–2351.9) |
| Job type | |||||
| Direct care of patients |
14,253.4 (12,328.2–16,479.3) |
8737.8 (8067.8–9463.4) |
4700.2 (4496.3–4913.2) |
2992.5 (2818.5–3177.3) |
2323.7 (2047.9–2636.6) |
| Indirect care of patients |
13,558.9 (10,955.9–16,780.5) |
7128.7 (6381.1–7964.0) |
3856.2 (3561.6–4175.3) |
2583.8 (2284.4–2922.5) |
1725.2 (1384.3–2150.1) |
| Ward | |||||
| COVID | 14,452.9 (12,661.1–16,498.3) |
8106.4 (7528.2–8728.0) |
4301.3 (4107.0–4504.9) |
2904.1 (2731.2–3088.0) |
2061.1 (1772.0–2397.3) |
| Not COVID | 12,959.1 (9887.4–16,985.2) |
8006.6 (6962.3–9207.5) |
4823.6 (4477.3–5196.7) |
2880.4 (2569.3–3229.2) |
2269.8 (1958.1–2631.1) |